Viewing Study NCT05380635


Ignite Creation Date: 2025-12-24 @ 10:38 PM
Ignite Modification Date: 2026-01-20 @ 2:30 PM
Study NCT ID: NCT05380635
Status: COMPLETED
Last Update Posted: 2023-06-07
First Post: 2022-05-09
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma
Sponsor: Soligenix
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cutaneous T-Cell Lymphoma/Mycosis Fungoides View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CTCL View
None MF View
None Hypericin View
None HyBryte View